can glp 1 cause inflammation GLP-1 Receptor Agonists Reduce Glucagon-like peptide-1 receptor agonists in

Long-term side risks could consist of the body generating antibodies against the drug, which could reduce its efficacy or cause new side effects

Consequently, the proportion of lean body mass relative to total body weight increased

Individuals with Cardiovascular Risk Factors Some studies suggest that GLP-1 shots may have cardiovascular benefits beyond their effects on blood sugar control and weight management

Although basic research should continue to explore the mechanisms of GLP-1RAs in modulating addictive behaviors, human research is needed to examine the safety and efficacy of GLP-1RAs, optimize dosing strategies, and evaluate their utility as part of combination therapies with established pharmacological and behavioral interventions